HEL cells
Human HEL cells were isolated from the bone marrow of a patient with Erythroleukemia.
Tumour growth in vivo
The cells were collected from a tissue culture flask and injected subcutaneously in the right flank of
SCID-CB17 mice. The resulting tumours were monitored by measuring two diameters with calipers,
and extrapolating the volume to a sphere.
The mice bearing HEL tumours can be treated by intra-peritoneal, intra-venous, intra-tumoral or
subcutaneous injection of the compounds. Per os administration is also possible.
Figure 1: (View PDF)
Tumour growth curve of the HEL cells as xenograft
Mean ± SEM (n=10; take rate 100%)
Antineo can also perform an IV implantation, using hCD45 Flow Cytometry as follow-up of tumour
progression.